Nutex Health (NASDAQ:NUTX – Get Free Report) had its price target hoisted by Maxim Group from $45.00 to $50.00 in a research report issued to clients and investors on Tuesday,Briefing.com Automated Import reports. The firm presently has a “buy” rating on the stock. Maxim Group’s price target would indicate a potential upside of 79.15% from the stock’s current price.
Separately, Benchmark upped their target price on shares of Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a report on Wednesday, August 21st.
View Our Latest Analysis on NUTX
Nutex Health Trading Down 11.6 %
Insiders Place Their Bets
In related news, CFO Jon Christian Bates acquired 1,350 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now directly owns 2,277 shares in the company, valued at $48,864.42. The trade was a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Insiders own 38.52% of the company’s stock.
Institutional Investors Weigh In On Nutex Health
A number of hedge funds have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC bought a new stake in Nutex Health during the 3rd quarter worth about $188,000. Thompson Davis & CO. Inc. acquired a new position in Nutex Health during the 3rd quarter valued at about $494,000. Finally, Essex Investment Management Co. LLC acquired a new position in Nutex Health during the 3rd quarter valued at about $1,579,000. Institutional investors own 5.32% of the company’s stock.
About Nutex Health
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Further Reading
- Five stocks we like better than Nutex Health
- What is Forex and How Does it Work?
- 3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
- Roth IRA Calculator: Calculate Your Potential Returns
- Lam Research Fueled by Unyielding AI Demand Growth
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Generac: 5 Reasons to Buy This Stock Before Year’s End
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.